Meijer-van Gelder ME - Search Results

1

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.

van Agthoven T, Sieuwerts AM, Meijer-van Gelder ME, Look MP, Smid M, Veldscholte J, Sleijfer S, Foekens JA, Dorssers LC. van Agthoven T, et al. J Clin Oncol. 2009 Feb 1;27(4):542-9. doi: 10.1200/JCO.2008.17.1462. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075277

2

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, Stoter G, Nooter K. Burger H, et al. Clin Cancer Res. 2003 Feb;9(2):827-36. Clin Cancer Res. 2003. PMID: 12576456

3

Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.

Berns EM, Klijn JG, Look MP, Grebenchtchikov N, Vossen R, Peters H, Geurts-Moespot A, Portengen H, van Staveren IL, Meijer-van Gelder ME, Bakker B, Sweep FC, Foekens JA. Berns EM, et al. Clin Cancer Res. 2003 Apr;9(4):1253-8. Clin Cancer Res. 2003. PMID: 12684392

4

Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease.

Meijer-van Gelder ME, Look MP, Peters HA, Schmitt M, Brünner N, Harbeck N, Klijn JG, Foekens JA. Meijer-van Gelder ME, et al. Cancer Res. 2004 Jul 1;64(13):4563-8. doi: 10.1158/0008-5472.CAN-03-3848. Cancer Res. 2004. PMID: 15231667

5

The prognostic value of BCAR1 in patients with primary breast cancer.

Dorssers LC, Grebenchtchikov N, Brinkman A, Look MP, van Broekhoven SP, de Jong D, Peters HA, Portengen H, Meijer-van Gelder ME, Klijn JG, van Tienoven DT, Geurts-Moespot A, Span PN, Foekens JA, Sweep FC. Dorssers LC, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6194-202. doi: 10.1158/1078-0432.CCR-04-0444. Clin Cancer Res. 2004. PMID: 15448007

6

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling.

Jansen MP, Foekens JA, van Staveren IL, Dirkzwager-Kiel MM, Ritstier K, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Portengen H, Dorssers LC, Klijn JG, Berns EM. Jansen MP, et al. J Clin Oncol. 2005 Feb 1;23(4):732-40. doi: 10.1200/JCO.2005.05.145. J Clin Oncol. 2005. PMID: 15681518

7

Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.

Martens JW, Nimmrich I, Koenig T, Look MP, Harbeck N, Model F, Kluth A, Bolt-de Vries J, Sieuwerts AM, Portengen H, Meijer-Van Gelder ME, Piepenbrock C, Olek A, Höfler H, Kiechle M, Klijn JG, Schmitt M, Maier S, Foekens JA. Martens JW, et al. Cancer Res. 2005 May 15;65(10):4101-17. doi: 10.1158/0008-5472.CAN-05-0064. Cancer Res. 2005. PMID: 15899800

8

How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.

Sieuwerts AM, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, Portengen H, Klijn JG, Foekens JA. Sieuwerts AM, et al. Clin Cancer Res. 2005 Oct 15;11(20):7311-21. doi: 10.1158/1078-0432.CCR-05-0560. Clin Cancer Res. 2005. PMID: 16243802

9

Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.

Sieuwerts AM, Look MP, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, de Weerd V, Portengen H, Klijn JG, Foekens JA. Sieuwerts AM, et al. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3319-28. doi: 10.1158/1078-0432.CCR-06-0225. Clin Cancer Res. 2006. PMID: 16740753

10

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.

Jansen MP, Sieuwerts AM, Look MP, Ritstier K, Meijer-van Gelder ME, van Staveren IL, Klijn JG, Foekens JA, Berns EM. Jansen MP, et al. J Clin Oncol. 2007 Feb 20;25(6):662-8. doi: 10.1200/JCO.2006.07.3676. J Clin Oncol. 2007. PMID: 17308270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters